Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,004 | 5,564 | 14,351 | 23,066 | 28,688 |
| Receivables | 6,783 | 2,977 | 2,414 | 3,377 | 3,523 |
| Inventories | 16,806 | 15,720 | 14,691 | 12,516 | 12,364 |
| TOTAL | $60,784 | $25,326 | $32,268 | $39,739 | $45,581 |
| Non-Current Assets | |||||
| PPE Net | 8,745 | 9,150 | 9,583 | 8,688 | 8,033 |
| Intangibles | 7,852 | 8,229 | 9,066 | 9,610 | 9,345 |
| Other Non-Current Assets | 6,662 | 6,872 | 6,497 | 6,855 | 7,028 |
| TOTAL | $23,259 | $24,250 | $25,146 | $25,153 | $24,406 |
| Total Assets | $84,043 | $49,577 | $57,414 | $64,892 | $69,987 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 300 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 10,183 | 8,091 | 8,397 | 10,043 | 6,559 |
| TOTAL | $11,426 | $9,428 | $9,434 | $12,351 | $11,193 |
| Non-Current Liabilities | |||||
| Long Term Debt | 18,333 | 18,478 | 18,327 | 18,182 | 18,040 |
| Deferred Revenues | 20 | 405 | 405 | 1,607 | 3,866 |
| Other Non-Current Liabilities | 6,208 | 6,393 | 6,198 | 6,327 | 6,449 |
| TOTAL | $24,698 | $25,045 | $24,694 | $24,765 | $24,855 |
| Total Liabilities | $36,125 | $34,473 | $34,128 | $37,116 | $36,048 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,045 | 28,623 | 20,245 | 20,182 | 20,176 |
| Common Shares | 301 | 203 | 203 | 202 | 202 |
| Retained earnings | -117,037 | -110,671 | -101,607 | -97,106 | -89,967 |
| Other shareholders' equity | -789 | -436 | -737 | -281 | -918 |
| TOTAL | $47,919 | $15,103 | $23,285 | $27,776 | $33,940 |
| Total Liabilities And Equity | $84,043 | $49,577 | $57,414 | $64,892 | $69,987 |